Dexxon Holdings Ltd. is 10% Owner at Urovant Sciences Ltd. (UROV). They have made 5 open-market trades across 3 companies since 2018, most recently 2019-05-29.
CIK 0001636684
5 open-market purchases totalling $57.9M since 2018, never a sale. Across 5 scored buys the stock is up 10.6% at ninety days, and 7.8 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 80% | 60% | 80% |
| Avg Move | +2.5% | +4.3% | +10.6% |
| Alpha | +3.2% | +2.4% | +7.8% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UROV | BUY | 2019-05-24 | 2019-05-29 | $7.62 | $110K | +7.2% | -0.4% | -4.7% |
| UROV | BUY | 2019-05-22 | 2019-05-28 | $7.91 | $78K | +5.2% | +3.5% | +5.3% |
| UROV | BUY | 2019-05-21 | 2019-05-23 | $8.52 | $85K | +3.6% | +4.3% | +1.6% |
| UROV | BUY | 2019-05-16 | 2019-05-20 | $7.09 | $82K | -6.8% | -0.8% | -4.4% |
| AXON | BUY | 2019-03-18 | 2019-03-19 | $1.50 | $10.0M | +4.1% | +14.5% | +30.4% |
| AXON | BUY | 2018-06-05 | 2018-06-07 | $1.75 | $25.0M | +3.8% | +6.0% | +8.9% |
| MYOV | BUY | 2018-04-02 | 2018-04-04 | $20.27 | $22.5M | +7.6% | -2.5% | +16.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.